PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Young adults drive historic decline in smoking

Despite gains, slower decline among adults over 50 may delay reductions in smoking-related deaths

2025-04-25
(Press-News.org) Researchers at University of California San Diego found that cigarette smoking continues to decline across the United States, largely driven by young adults. Their study, published in JAMA Network Open on April 25, 2025, reveals that the states with historically high smoking rates have seen the most dramatic declines. However, smoking cessation progress among adults over 50 has been much slower, which could prolong the public health burden of smoking-related diseases and death.

“The rapid decline in smoking among young adults is clear evidence that the smoking epidemic will come to an end in our lifetime,” said Matthew Stone, Ph.D., first author and assistant professor at the UC San Diego Herbert Wertheim School of Public Health and Human Longevity Science and Moores Cancer Center member. “Indeed, we project that the national smoking prevalence will be under 5% by 2035. However, the much slower decline in smokers over the age of 50, particularly in previously high smoking states, will mean that the high rates of lung cancer, heart disease and chronic obstructive pulmonary disease that are caused by lifelong smoking will take longer to decrease.”

Researchers used the publicly available Tobacco Use Supplements to the U.S. Census Bureau’s Current Population Survey. The survey is a large — approximately 54,000 households — monthly representative survey that provides information on employment and economic well-being. For this study, all analyses were conducted between June and October 2024. A total of 1.77 million respondents were analyzed.

The study found:

Large differences in smoking prevalence existed across U.S. states in both the 1990s and in 2022, when the study authors obtained smoking prevalence estimates. The most significant decline in smoking happened in states with historically high smoking rates. Differences in prevalence across age, sex, race and ethnicity, and education persisted across the years. There was a larger decline in young adult smoking compared with other states with lower historical rates of smoking. However, the gain was offset by a much slower decline among adults 50 and older. Since the 1950s, when researchers first linked smoking to lung cancer, national smoking rates have dropped dramatically. In 1955, 56.9% of U.S. adults smoked. By the turn of the century, that figure had fallen by more than half, and by 2022, it had dropped again by 50%. The trend is expected to continue, with smoking rates projected to halve again by 2035. Recent evidence indicates that states that have made the greatest progress in reducing smoking have also seen the largest declines in lung cancer mortality — typically with a 16-year lag.

“While the ongoing decline in cigarette smoking is a major public health success story,” said John P. Pierce, Ph.D., corresponding author and Distinguished Professor at the Herbert Wertheim School of Public Health and Human Longevity Science and Moores Cancer Center. “Recent evidence suggests that the tobacco industry has successfully recruited a new generation of  teenagers into e-cigarette use and nicotine addiction. Further research is needed to assess the long-term impact of this shift.”

# # #

Additional co-authors on the study include: Brian Dang, M.S., Sara B. McMenamin, Ph.D., David R. Strong, Ph.D., Yuyan Shi, Ph.D., Karen Messer, Ph.D., and Dennis R. Trinidad, Ph.D., at UC San Diego; Candice D. Donaldson, Ph.D., and Xueying Zhang, M.D., from the Tobacco Control Branch, California Department of Public Health (CDPH).

The study was funded, in part, by the Tobacco-Related Disease Research Program (TRDRP) of the University of California Office of the President (Nos. T31Ir-1584 and T32IR-4988) and CDPH (No. 22-10341.)

# # #

END


ELSE PRESS RELEASES FROM THIS DATE:

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

2025-04-25
NFCR Congratulates Dr. Robert C. Bast, Jr. on Receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research Rockville, MD — The National Foundation for Cancer Research (NFCR) proudly congratulates Dr. Robert C. Bast, Jr., a pioneering cancer scientist, and NFCR-supported investigator from 2001 to 2018, on being named the 2025 recipient of the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research. Presented by the American Association for Cancer Research (AACR), ...

Chimpanzee stem cells offer new insights into early embryonic development

2025-04-25
Understanding how cells differentiate during early embryonic development is crucial for advancing regenerative medicine and developmental biology. Pluripotent stem cells (PSCs) have been invaluable tools in this field, as they can transform into various cell types in the body and play key roles during early embryonic development. Unfortunately, research on this topic in humans and other primates has long been hampered by ethical constraints and technical limitations. Of particular interest are naive-type PSCs, which represent an earlier developmental state than conventional (or ‘primed’) PSCs and possess enhanced differentiation potential. While human naive PSCs can differentiate ...

This injected protein-like polymer helps tissues heal after a heart attack

2025-04-25
Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure.   The therapy both prompts the immune system to encourage tissue repair and promotes survival of heart muscle cells after a heart attack. Researchers tested the therapy in rats and showed that it is effective up to five weeks after injection.  The research team, led by bioengineers at the University of California San Diego and chemists at Northwestern University, published ...

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

2025-04-25
FlexTech, an international academic journal (ISSN 2771-1706), jointly published by Tsinghua University Press and Wiley Publishing Group, has officially released its first issue. Supported by Tsinghua University’s State Key Laboratory of Flexible Electronics Technology, the journal aims to serve as a global platform for scholars to advance cutting-edge research and engineering applications in flexible materials, devices, and systems, driving humanity toward an intelligent era.   Editor-in-Chief’s Vision: Bridging Humanity, Machines, and the Digital World In his inaugural editorial, Prof. Xue Feng from Tsinghua University, Editor-in-Chief ...

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

2025-04-25
Studies by a growing number of labs have identified neurological health benefits from exposing human volunteers or animal models to light, sound and/or tactile stimulation at the brain’s “gamma” frequency rhythm of 40Hz. In the latest such research at The Picower Institute for Learning and Memory and Alana Down Syndrome Center at MIT, scientists found that 40Hz sensory stimulation improved cognition and circuit connectivity and encouraged the growth of new neurons in mice genetically engineered to model Down syndrome. Li-Huei Tsai, Picower Professor at MIT and senior author of the new study in PLOS ONE, said that the results are encouraging but also cautioned ...

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

2025-04-25
Methyl eugenol (ME), a phenylpropanoid compound found in the essential oils of various aromatic plants, has recently garnered attention due to its significant antioxidant, anticancer, and neuroprotective properties. ME, commonly used in the fragrance and food industries, is also studied for its potential therapeutic effects, particularly in mitigating diseases associated with oxidative stress, such as Alzheimer’s disease, cancers, and ischemic brain injuries. However, despite its therapeutic promise, concerns ...

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

2025-04-25
A research article published by the Shanghai University presented a novel microfluidic chip design with a 3-layer configuration that utilizes a polycarbonate (PC) porous membrane to separate the culture fluid channels from the tissue chambers, featuring flexibly designable multitissue chambers. PC porous membranes act as the capillary in the vertical direction, enabling precise hydrogel patterning and successfully constructing a microfluidic environment suitable for microvascular tissue growth. The new research paper, published on Feb. 28, 2025 in the journal Cyborg and Bionic Systems, presented a flexible and scalable chip that is highly suitable for culturing multiple ...

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

2025-04-25
A new study found that a gene recently recognized as a biomarker for Alzheimer’s disease is actually a cause of it, due to its previously unknown secondary function. Researchers at the University of California San Diego used artificial intelligence to help both unravel this mystery of Alzheimer’s disease and discover a potential treatment that obstructs the gene’s moonlighting role. The research team published their results on April 23 in the journal Cell.  About one in nine people aged 65 ...

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

2025-04-25
Coalition of Autism Scientists Critiques U.S. Department of Health and Human Services Autism Research Initiative Boston, MA, April 25, 2025 – The newly formed Coalition of Autism Scientists today issued a statement in response to remarks and actions taken by Robert F. Kennedy, Jr., Secretary of the U.S. Department of Health and Human Services (HHS) regarding the study of autism. Led by Helen Tager-Flusberg, Ph.D., Professor Emerita, Department of Psychological & Brain Sciences, Director of the Center for Autism Research, Boston University, this growing group of experienced research scientists from ...

Structure dictates effectiveness, safety in nanomedicine

2025-04-25
Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The specific location of each atom within the drug molecule is a critical factor in determining how well it works and how safe it is. In ibuprofen, for example, one molecule is effective as a pain reliever, but the mirror image of that same molecule is completely inactive. Now, Northwestern University and Mass General Brigham scientists argue that this precise structural control, which is applied to traditional medicines, should be harnessed to usher in a new class of potent nanomedicines that can ...

LAST 30 PRESS RELEASES:

Let’s get on pancreatic cancer’s nerves

Intermittent fasting cut Crohn’s disease activity by 40% and halved inflammation in randomized clinical trial

New study in JNCCN unlocks important information about how to treat recurring prostate cancer

Simple at-home tests for detecting cat, dog viruses

New gut-brain discovery offers hope for treating ALS and dementia

Cognitive speed training linked to lower dementia incidence up to 20 years later

Businesses can either lead transformative change or risk extinction: IPBES

Opening a new window on the brainstem, AI algorithm enables tracking of its vital white matter pathways

Dr. Paul Donlin-Asp of the University of Edinburgh to dissect the molecular functions and regulation of local SYNGAP1 protein synthesis with support from CURE SYNGAP1 (fka SynGAP Research Fund)

Seeing the whole from a part: Revealing hidden turbulent structures from limited observations and equations

Unveiling polymeric interactions critical for future drug nanocarriers

New resource supports trauma survivors, health professionals  

Evidence of a subsurface lava tube on Venus

New trial aims to transform how we track our daily diet

People are more helpful when in poor environments

How big can a planet be? With very large gas giants, it can be hard to tell

New method measures energy dissipation in the smallest devices

More than 1,000 institutions worldwide now partner with MDPI on open access

Chronic alcohol use reshapes gene expression in key human brain regions linked to relapse vulnerability and neural damage

Have associations between historical redlining and breast cancer survival changed over time?

Brief, intensive exercise helps patients with panic disorder more than standard care

How to “green” operating rooms: new guideline advises reduce, reuse, recycle, and rethink

What makes healthy boundaries – and how to implement them – according to a psychotherapist

UK’s growing synthetic opioid problem: Nitazene deaths could be underestimated by a third

How rice plants tell head from toe during early growth

Scientists design solar-responsive biochar that accelerates environmental cleanup

Construction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases

Deep learning-based discovery of tetrahydrocarbazoles as broad-spectrum antitumor agents and click-activated strategy for targeted cancer therapy

DHL-11, a novel prieurianin-type limonoid isolated from Munronia henryi, targeting IMPDH2 to inhibit triple-negative breast cancer

Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model

[Press-News.org] Young adults drive historic decline in smoking
Despite gains, slower decline among adults over 50 may delay reductions in smoking-related deaths